CD8A and type 1 diabetes mellitus: Here we have applied this system to two distinct T1D contexts: pre-clinical models of CD4 and CD8-mediated T1D, and an allogenic islet transplant model in which full MHC mismatched donor islets are transferred to recipients after islet depletion.